Drug firm Venus Remedies received additional patent approval from USPTO for its product 'Vancoplus', used for treating bacterial infections.

Venus Remedies aims to launch its major products in global markets with an eye on more than doubling revenues to Rs 1,000 cr by 2016-17.

Venus Remedies today said its net profit increased by 28.42 per cent to Rs 15.09 crore for the quarter ended September 30, 2012 mainly on a...

The patent has been granted by Mexico Patent office and is valid till February 2026, Venus said in a release.

Venus Remedies Limited, a leading research based global pharmaceutical company has secured its first patent from Canada for its novel antib...

Venus Remedies has got US patent for Potentox, used for pneumonia other infections and is looking at increasing presence in the $ 12 bn ant...

Drug firm Venus Remedies today reported 14.91 per cent increase in net profit to Rs 15.56 crore for the quarter ended March 31.

Drug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.

Drug firm Venus Remedies today said it has received patents in South Africa and New Zealand for its product -- Vancoplus, used in treatment...